Radiotherapy Researcher, currently Head of Radiotherapy Developments at the Christie NHSFT and Senior Lecturer (Cancer Sciences) at the University of Manchester. Research interests include HBP cancers, normal tissue toxicity mitigation & imaging biomarker validation. Formerly of the Princess Margaret Hospital (PMH), Toronto, where works focused on imaging, motion management & RT planning for liver SABR. Subsequently relocating to the UK to complete a DPhil (Oxon) with Profs KA Vallis & WG McKennna. using novel imaging to detect early RT induced toxicities following RT + PI3k-inhibitors pre-clinically. Current works in Manchester are focused on MRI guided, Proton Beam RT in multiple tumour sites.